OTC · ETRGF
Entourage Health Corp.
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
Loading market information…
OTC · RGTPQ · USD
Stock price
Quote as of Apr 17, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
RegenETP, Inc.’s quoted price sits in the upper half of its reported 52-week range, 27.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
RegenETP, Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Salt Lake City, Utah. This company specializes in advancing and bringing to market a diverse array of regenerative tissue solutions and biological materials across the fields of medicine, biomedical engineering, and materials science within the United States. Its operations are structured into two main divisions: Regenerative Medicine Products and Contract Services. The company's primary offering is SkinTE, an innovative tissue product engineered for the restoration, rebuilding, or augmentation of skin. This therapy is employed in patients to address various conditions such as severe or persistent wounds, burns, post-surgical recovery, scar reduction, or the removal of impaired skin grafts. In addition to its product sales, RegenETP also furnishes specialized contract research services. Currently in its pipeline, the company is developing SkinTE Cryo, which utilizes a cryopreservation method to allow for multiple applications from a single original tissue harvest. It is also progressing a SkinTE point-of-care device, designed to facilitate immediate, on-site processing and application of SkinTE following the initial tissue collection, alongside other future regenerative tissue developments. The company previously operated as PolarityTE, Inc., before rebranding to RegenETP, Inc. in August 2023.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
$0.01+$0.01 (+316.67%)
Novation Companies, Inc.: Healthcare · Medical - Care Facilities.
$0.37+$0.04 (+12.12%)
InVivo Therapeutics Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.76% below the high.
$0.01+$0.00 (+4.0%)
Digipath, Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.14% below the high.
$0.00$0.00 (0.0%)
Nutroganics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Suvanza Pharma, LLC’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01-$0.00 (-12.9%)
Pure Extracts Technologies Corp.’s quoted price sits in the lower half of its reported 52-week range, 12.9% below the high.
CA$0.10CA$0.00 (0.0%)
Asep Medical Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
